Ameriprise’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-17,500
| Closed | -$298K | – | 3771 |
|
|
2019
Q2 | $298K | Sell |
17,500
-931
| -5% | -$15.9K | ﹤0.01% | 3471 |
|
|
2019
Q1 | $621K | Buy |
18,431
+8,238
| +81% | +$278K | ﹤0.01% | 3212 |
|
|
2018
Q4 | $298K | Buy |
10,193
+8,880
| +676% | +$260K | ﹤0.01% | 3344 |
|
|
2018
Q3 | $80K | Buy |
1,313
+7
| +0.5% | +$427 | ﹤0.01% | 3631 |
|
|
2018
Q2 | $96K | Buy |
+1,306
| New | +$96K | ﹤0.01% | 3560 |
|
|
2018
Q1 | – | Sell |
-1,397
| Closed | -$118K | – | 3705 |
|
|
2017
Q4 | $118K | Buy |
+1,397
| New | +$118K | ﹤0.01% | 3538 |
|
|
2017
Q2 | – | Sell |
-19,250
| Closed | -$2.38M | – | 3798 |
|
|
2017
Q1 | $2.38M | Buy |
19,250
+4,395
| +30% | +$542K | ﹤0.01% | 2502 |
|
|
2016
Q4 | $2.02M | Buy |
+14,855
| New | +$2.02M | ﹤0.01% | 2616 |
|